Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

1.6K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.6K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

72
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
72

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Water hyacinth-derived biochars - from invasive biomass to active Pt-free alkaline oxygen reduction reaction catalysts.

Journal of colloid and interface science·2026
Same author

Photoactivated bioinspired lipoplexes with a chalcone/flavylium photoswitch enhance siRNA delivery-towards precise spatiotemporal control in gene delivery.

Journal of materials chemistry. B·2025
Same author

Smart sarcosinate-based catanionic vesicles for efficient doxorubicin delivery in tumor microenvironments.

Nanoscale·2025
Same author

Unraveling the self-assembly and molecular interactions of a bio-inspired, vesicle-forming surfactant with block copolymers of varying hydrophobic/hydrophilic balance.

Journal of colloid and interface science·2025
Same author

Evaluating the Impact of Newborn Screening for Cystic Fibrosis in Portugal: A Decade of Insights and Outcomes.

International journal of neonatal screening·2025
Same author

Early life behavioral deficits and microglia remodeling in the mesocorticolimbic system precede the emergence of Schizophrenia-like symptoms.

Brain, behavior, and immunity·2025

Related Experiment Video

Updated: Apr 18, 2026

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery
08:09

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery

Published on: August 6, 2019

6.3K

Gemini surfactants mediate efficient mitochondrial gene delivery and expression.

Ana M Cardoso1, Catarina M Morais, A Rita Cruz

  • 1CNC-Center for Neuroscience and Cell Biology, ‡Department of Life Sciences, and §Faculty of Pharmacy, University of Coimbra , Coimbra, Portugal.

Molecular Pharmaceutics
|January 31, 2015
PubMed
Summary

Gemini surfactants effectively deliver plasmid DNA to mitochondria, offering a novel approach for treating mitochondrial genetic diseases. This breakthrough facilitates targeted gene therapy by enhancing cellular uptake and DNA release within mitochondria.

Keywords:
complex sizecomplex surface chargecomplex−membrane interactionsgemini surfactantsmitochondriaserinetransfection

More Related Videos

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
09:45

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Published on: March 31, 2015

11.9K
Author Spotlight: Advancing Techniques and Discoveries in Protein Synthesis and Assembly Through Innovative Mitochondrial Research
09:53

Author Spotlight: Advancing Techniques and Discoveries in Protein Synthesis and Assembly Through Innovative Mitochondrial Research

Published on: June 7, 2024

1.8K

Related Experiment Videos

Last Updated: Apr 18, 2026

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery
08:09

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery

Published on: August 6, 2019

6.3K
Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
09:45

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Published on: March 31, 2015

11.9K
Author Spotlight: Advancing Techniques and Discoveries in Protein Synthesis and Assembly Through Innovative Mitochondrial Research
09:53

Author Spotlight: Advancing Techniques and Discoveries in Protein Synthesis and Assembly Through Innovative Mitochondrial Research

Published on: June 7, 2024

1.8K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Genetics

Background:

  • Mitochondrial genetic diseases represent a significant therapeutic challenge.
  • Targeted gene delivery to mitochondria is crucial for developing effective treatments.
  • Current gene delivery methods often struggle with mitochondrial specificity and efficiency.

Purpose of the Study:

  • To develop a novel gene delivery system for mitochondria using gemini surfactants.
  • To investigate the mechanism of cellular uptake and intracellular trafficking of gemini surfactant-DNA complexes.
  • To evaluate the potential of this system for gene therapy of mitochondrial diseases.

Main Methods:

  • Design of a plasmid DNA construct for mitochondrial expression using a unique codon.
  • Formulation of gemini surfactant-DNA complexes.
  • Cellular uptake studies using various cell lines and endocytic pathway inhibitors.
  • In vitro studies using lipid membrane models mimicking mitochondrial membranes.
  • Assessment of DNA release under acidic conditions.

Main Results:

  • Gemini surfactants successfully delivered plasmid DNA to mitochondria.
  • Cellular uptake occurred via multiple pathways, including endocytosis.
  • Complexes demonstrated membrane destabilization under acidic conditions, aiding cytoplasmic DNA release.
  • Extensive interaction with mitochondrial lipid membrane models was observed, predicting favorable intracellular targeting.

Conclusions:

  • Gemini surfactants represent a promising non-viral vector for mitochondrial gene delivery.
  • The developed system facilitates targeted gene therapy for mitochondrial genetic disorders.
  • This approach offers new possibilities for transforming the treatment landscape of mitochondrial diseases.